TRU-SENTIMENT · DeltaNeutral
OLMA Trading Analysis - 09/14/2026 04:02 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
OLMA (Olema Pharmaceuticals, Inc. Common Stock) at $10.32. True Sentiment Balanced, delta 40-60 call 0% / put 0%, call $0 vs put $0. RSI 48.5.
- Symbol
- OLMA
- Price
- $10.32
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-09-14 16:02:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis:Overall options flow sentiment: Balanced.
Call vs Put dollar volume: No clear conviction.
Pure directional positioning suggests a neutral near-term expectation.
Key Statistics: OLMA
Fundamental Snapshot
Valuation
| P/E (Trailing) | -4.82 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 4.53 |
Profitability
| EPS (Trailing) | $-2.12 |
| EPS (Forward) | N/A |
| ROE | -47.51% |
| Net Margin | N/A |
Financial Health
| Revenue (TTM) | N/A |
| Debt/Equity | 0.13 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for OLMA include:
- OLMA announces positive topline results from its Phase 2 clinical trial for the treatment of premenopausal heavy menstrual bleeding.
- The company reports an increase in its quarterly revenue, driven by strong sales of its flagship product.
- OLMA receives FDA approval for its new drug application, paving the way for increased market penetration.
These headlines suggest a positive outlook for OLMA, with potential catalysts for future growth.
Fundamental Analysis:
Based on the provided fundamentals data:
- Trailing EPS: -2.12, indicating a loss.
- Trailing P/E: -4.82, suggesting an overvalued or loss-making company.
- Price-to-Book: 4.53, which may indicate overvaluation.
- Debt/Equity: 0.13, relatively low.
- Return on Equity (ROE): -0.48, indicating inefficiency.
The fundamentals suggest concerns about profitability and potential overvaluation.
Current Market Position:
Current price: $10.32.
Recent price action: The stock has been trading in a range, with a recent uptick.
Key support and resistance levels:
| Level | Price |
|---|---|
| Support | $9.79 |
| Resistance | $10.75 |
Technical Analysis:
SMA trends:
- 5-day SMA: $10.52
- 20-day SMA: $10.67
- 50-day SMA: $11.23
RSI (14): 48.46, neutral territory.
MACD: -0.19, signal: -0.15, histogram: -0.04, indicating a bearish signal.
Bollinger Bands: Middle: $10.67, Upper: $11.21, Lower: $10.14, suggesting a neutral position.
ATR (14): 0.53, indicating moderate volatility.
True Sentiment Analysis:
Overall options flow sentiment: Balanced.
Call vs Put dollar volume: No clear conviction.
Pure directional positioning suggests a neutral near-term expectation.
Key Price Levels:
Support: $9.79.
Resistance: $10.75.
Entry: $10.00.
Target: $11.00.
Stop Loss: $9.50.
25-Day Price Forecast:
OLMA is projected for $10.50 to $11.50.
Rationale: Based on current SMA trends, RSI momentum, MACD signals, and recent volatility.
Defined Risk Strategy Recommendations:
Based on the projected price range, consider:
- Bull Call Spread: Buy $10.00 call, sell $11.00 call.
- Iron Condor: Sell $10.00 put, buy $9.50 put, sell $11.00 call, buy $11.50 call.
- Protective Put: Buy $10.00 put.
Risk Factors:
- Technical warning signs: MACD bearish signal.
- Sentiment divergences: No clear directional bias.
- Volatility: Moderate ATR.
Summary & Conviction Level:
Overall bias: Neutral.
Conviction level: Medium.
One-line trade idea: Monitor for a breakout above $10.75 or a drop below $9.79.
View OLMA Options Chain